Jacob Hooker

@Scott_LabUM @rsc_medchem @MadisonFrazier1 @jays_wright @afallenbrooks Nice studies on this Pete and team!! Love seeing the activity in activity based probe and ion channel imaging!!

Our latest paper describes automated synthesis and preclinical imaging of a novel [18F]Fluorolidocaine analog via sequential C-H radiolabeling and is out in @rsc_medchem. Congrats @MadisonFrazier1 (1st paper!) @jays_wright @afallenbrooks. Read it here: pubs.rsc.org/en/Content/Art…

@Eikonizo is excited to be in Philly for the @alzassociation #AAIC24. A great opportunity to learn from and meet with some of the best and brightest in dementia research. If you see our CEO @RickLundberg, be sure to stop and say hello!

Wow. The Harris team are out of the blocks in lightening quick time with this superb ad twitter.com/AdamJSmithGA/s…

@cathleencrudden Why yikes? This is one of many amazing “reset” buttons for the brain. We have a lot to learn, but insights and mechanisms related to psychedelics could be a major contributor to solving the mental health crisis.

📢Stay up to date with the latest📢 This new collection of #ACSChemNeuro research joins the discussion around #MDMA as a potential breakthrough therapy Read the latest research ➡ go.acs.org/9Mn

And that's a wrap on #BIO2024! Our CEO, @RickLundberg, spent a busy few days meeting with #biotech & #pharma industry partners and investors while still making time to enjoy some of the sights in beautiful San Diego.

@zenbrainest @US_FDA Yes. This challenge will pervade the space. Time for some trial innovation!

My prediction: The concerns about expectation bias and unblinding will cause problems for classical psychedelics going forward. #psychedelics @US_FDA

📢New collection of #ACSChemNeuro research as the FDA is expected to announce a decision on a new treatment involving #MDMA today ⏰ Read the latest research ➡ go.acs.org/9Er

FDA Advisory Committee votes against recommending Lykos' #MDMA treatment for PTSD Read our latest MDMA research here ➡ go.acs.org/9Er

@RCarhartHarris curious your take if you listened to the discussion part of the meeting.

@ACSChemNeurosci @zenbrainest Super interesting discussion about expectancy bias… check out pubs.acs.org/doi/10.1021/ac…

Overall, I thought the discussion was less focused on the tremendous unmet need. Maybe I’m a bit too cavalier, but I certainly felt the benefits outweigh the risks (with plenty of guardrail caveats).

Fascinating discussions online today surrounding the FDA's consideration of a new #MDMA treatment for PTSD 🤔 When is a double-blinded study not enough? How can you blind for a treatment that includes such pronounced and well-known effects? Let us know what you think! ⬇

@jmhooker @zenbrainest want to kick off the discussion?

Today the world can watch a film that has been called “the best movie I have seen in 30 years.” For Love & Life: No Ordinary Campaign is now streaming on @PrimeVideo. After you watch the documentary, please review it on the Amazon page for the film. amazon.com/gp/video/detai…

Whoo hoo! Major paper now out in @science : "AlphaFold2 structures guide prospective ligand discovery" Collaboration with @RothLabUNC @BShoichet Skiniotis, Kruse, @EnamineLtd

@Nature Love this!! Love this!! Love this!!

An orangutan in Sumatra surprised scientists when he was seen treating an open wound on his cheek with a poultice made from a medicinal plant go.nature.com/3UrXtjk

Neuroimaging, blood proteomics, and health data from 30 military personnel show that increased exposure to explosive blasts was associated with structural and functional brain alterations and a decrease in health-related quality of life. In PNAS: ow.ly/bfNA50RpWfO